Literature DB >> 3048318

Protection against fatal Klebsiella pneumoniae sepsis in the squirrel monkey Saimiri sciureus after immunization with a capsular polysaccharide vaccine.

J M Postal1, J Gysin, Y Crenn.   

Abstract

An anti-Klebsiella pneumoniae K5a capsular polysaccharide vaccine was evaluated as a preventive approach for protecting squirrel monkeys, Saimiri sciureus, in our breeding colony. Based on an 8-month vaccination schedule over a period of more than two years, this vaccine, regardless of the animal's age, resulted in a reduction of this particular bacterial infection and its generally associated fatal outcome. IgG antibody responses in naive and vaccinated animals were monitored over an extended period by radioimmunoassay and showed a marked increase above the initial naturally occurring antibody titres. No side-effects were observed after repeated vaccination of several hundred animals during a two-year period.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3048318     DOI: 10.1016/0769-2625(88)90066-9

Source DB:  PubMed          Journal:  Ann Inst Pasteur Immunol        ISSN: 0769-2625


  3 in total

1.  Molecular characterization of major histocompatibility complex class 1 (MHC-I) from squirrel monkeys (Saimiri sciureus).

Authors:  Hervé Pascalis; Jean-Michel Heraud; Rolf Fendel; Anne Lavergne; Mirdad Kazanji
Journal:  Immunogenetics       Date:  2003-10-22       Impact factor: 2.846

2.  Vaccine Protection against Multidrug-Resistant Klebsiella pneumoniae in a Nonhuman Primate Model of Severe Lower Respiratory Tract Infection.

Authors:  Natalia Malachowa; Scott D Kobayashi; Adeline R Porter; Brett Freedman; Patrick W Hanley; Jamie Lovaglio; Greg A Saturday; Donald J Gardner; Dana P Scott; Amanda Griffin; Kathleen Cordova; Dan Long; Rebecca Rosenke; Daniel E Sturdevant; Daniel Bruno; Craig Martens; Barry N Kreiswirth; Frank R DeLeo
Journal:  mBio       Date:  2019-12-17       Impact factor: 7.867

Review 3.  Klebsiella pneumoniae capsule polysaccharide as a target for therapeutics and vaccines.

Authors:  Clement Opoku-Temeng; Scott D Kobayashi; Frank R DeLeo
Journal:  Comput Struct Biotechnol J       Date:  2019-10-25       Impact factor: 7.271

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.